Status:
COMPLETED
A De-Escalating Strategy for Antibiotic Treatment of Pneumonia in The Medical Intensive Care Unit (0787B-092)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Infection
Pneumonia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The primary objective of this study is a comparison between MK0787B and standard therapy.
Eligibility Criteria
Inclusion
- Greater than 18 years of age
- Patient is diagnosed with nosocomial pneumonia
Exclusion
- Immunological deficient patients
- Pregnant women and nursing mothers
- A fungus is identified before the study enrollment
- Received vancomycin or imipenem for more than 5 days before icu admission
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2007
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00445094
Start Date
November 1 2006
End Date
January 1 2007
Last Update
February 17 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.